<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>‘Living drug’ offers hope to terminal blood cancer patients</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2019/06/22/living-drug-offers-hope-to-terminal-blood-cancer-patients.aspx</link><description>Thanks to a pioneering treatment, some patients with lymphoma are being cured in a miraculous way. CAR-T therapy , a treatment that genetically reprograms the immune system to fight cancer, is a &amp;ldquo;living drug&amp;rdquo; that is tailor-made for each cancer</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>